All In MedTech

Device Trial Radar · NCT01729247

Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age

Last checked: Nov 19, 2026Latest source record: Mar 3, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

50

Actual

Start

Oct 2012

Primary completion

Nov 2012

Study completion Nov 2012

Sponsor

Lead sponsor
Aerocrine ABNot on our public-company list
Sponsor type
Industry
First posted
Nov 20, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 7 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Objective: To evaluate the impact of FeNO assessments on asthma treatment decisions. Secondary objectives: Evaluate the ability of physicians to correctly assess airway inflammation using standard clinical assessment tools (i.e., prior to FeNO measurement). Estimate the cost consequences of changes in asthma management following FeNO determinations Number of participants: Approximately 40 to 50 subjects will participate in the study during an (approximately) 8-12 week study enrollment period. Reference product: NIOX MINO® Instrument (09-1100) Performance assessments: Fractional Exhaled Nitric Oxide (FeNO) Measurements will be performed according to the "Perform FeNO Measurement" guidelines on page 7 of the NIOX MINO® User Manual (February, 2011). Response to Study Physician Questions before (Questions 1, 2, and 3) and after (Question 4) FeNO has been measured and seen by the Physician/Health Care Practitioner. Safety assessments: The Investigator is responsible for the detection, reporting, and documentation of events meeting the definition of an Adverse Event (AE) and/or Serious Injuries as provided in this clinical investigation plan (CIP) from the time that informed consent has been provided and during the study period Criteria for evaluation: This is an observational, pilot study and there are currently no plans for a formal statistical analysis. Information gained from this study may be used to design subsequent studies in subjects with asthma. Data collected will be summarized in a clinical study report but will not be subject to formal hypothesis testing

Conditions

  • Asthma

Interventions

  • NIOX MINO® Instrument (09-1100)Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. FeNO Values by ACT ScoreTime frame: Study Visit (single visit study). Approximately 1 hour.
  2. FeNO Categorical Levels by ICS UseTime frame: Study visit (single visit study). Approximately1 hour.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • North Carolina Clinical Research

    Raleigh, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.